Gossamer Bio Inc. (GOSS) Tops Q3 EPS by 5c

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q3 EPS of ($0.21), $0.05 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• JPMorgan cuts 2026 box office forecast on slow third quarter
• Goldman Sachs reports global fund inflows for week of July 8